Afuco™ Anti-Human FAS ADCC Therapeutic Antibody (F45D9), ADCC Enhanced
Anti-FAS ADCC Enhanced Antibody (F45D9) is an ADCC enhanced antibody produced by our Afuco™ platform. F45D9 is a human monoclonal antibody that blocks Fas ligand induced apoptosis by binding to the Fas receptor. It can be used for the treatment of immune disorders and diseases that include ischemia/reperfusion injury, HIV, and cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-248CL |
| Pricing | Inquiry |
| Host | Human |
| Target | FAS |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4 °C, -20°C if preferred |